Abstract:Background : The vascular endothelium plays a fundamental role in the health and disease of the cardiovascular system. However, the molecular mechanisms regulating endothelial homeostasis remain incompletely understood. CCN3, a member of the CCN (Cyr61, Ctgf, Nov) family of cell growth and differentiation regulators, has been shown to play an important role in numerous cell types. While CCN3 expression in endothelial cells has been described, its function in this cell type has yet to be elucidated. Methods and Results : A detailed immunohistochemical analysis of CCN3 expression in mouse tissues revealed robust immunoreactivity in the endothelium of large arteries, small resistance vessels, as well as veins. Likewise, CCN3 expression is observed in cultured human endothelial cells derived from a variety of vascular beds. CCN3 expression in human umbilical vein endothelial cells (HUVECs) is transcriptionally induced by laminar shear stress (LSS) by ~27-fold. Similarly, treatment of HUVEC with HMG CoA-reductase inhibitors (statins) induced CCN3 expression by ~32-fold. A combination of promoter deletion and mutational analyses coupled with chromatin immuno-precipitation studies identified the Kruppel-like factor 2 as a direct regulator of CCN3 expression. In contrast to LSS, proinflammatory cytokines such as TNF α reduced CCN3 expression. Functionally, adenoviral overexpression of CCN3 in HUVEC markedly inhibited the cytokine-mediated induction of VCAM-1. Consistent with this observation, CCN3 overexpression significantly reduced monocyte adhesion. Conversely, siRNA mediated “knockdown” of CCN3 protein in HUVECs resulted in enhancement of cytokine-induced VCAM-1 expression. Concordant effects were observed on monocyte adhesion. Mechanistically, gain and loss-of-function studies demonstrate that CCN3 negatively regulates NF- κ B activity by reducing its translocation into nucleus and DNA binding to VCAM-1 promoter, suggesting that CCN3’s anti-inflammatory effects occur secondary to inhibition of NF- κ B nuclear accumulation. Conclusions: This study identifies CCN3 as a novel regulator of endothelial proinflammatory activation.

The subcellular redistribution of NLRC5 promotes angiogenesis via interacting with STAT3 in endothelial cells

Long Noncoding RNA MEG3 Mediated Angiogenesis after Cerebral Infarction Through Regulating P53/nox4 Axis.

Toll-like Receptor 2 in Promoting Angiogenesis after Acute Ischemic Injury.

NLGN3 contributes to angiogenesis in myocardial infarction via activation of the Gαi1/3-Akt Pathway

Endothelial PRMT5 Plays a Crucial Role in Angiogenesis after Acute Ischemic Injury

NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer

NLRC5 Inhibits Neointima Formation Following Vascular Injury and Directly Interacts with PPARγ

Endothelial G protein stimulatory alpha-subunit is a critical regulator of post-ischemic angiogenesis

STAT6 Upregulates NRP1 Expression in Endothelial Cells and Promotes Angiogenesis

Abstract 4954: A Novel Role of CCN3 in Regulating Endothelial Inflammation

Nxhl Controls Angiogenesis by Targeting VE-PTP Through Interaction with Nucleolin.

DCBLD1 modulates angiogenesis by regulating of the VEGFR-2 endocytosis in endothelial cells

Endothelial G protein stimulatory α-subunit is a critical regulator of post-ischemic angiogenesis

TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis

The ER membrane protein complex subunit Emc3 controls angiogenesis via the FZD4/WNT signaling axis

ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction

RNF20-mediated transcriptional pausing and VEGFA splicing orchestrate vessel growth

A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis

Yes-Associated Protein Promotes Angiogenesis via Signal Transducer and Activator of Transcription 3 in Endothelial CellsNovelty and Significance

Knockdown of NLRC5 attenuates renal I/R injury in vitro through the activation of PI3K/Akt signaling pathway.

Activating α7nAChRs enhances endothelial progenitor cell function partially through the JAK2/STAT3 signaling pathway